Tumor Marker Elevation: Chromogranin

Tumor Marker Elevation: Chromogranin

User Options

Hover over an icon for more information

Additional Topics Details for this Page

Article Count - 1
Cumulative Knowledge - 10

Advanced Database Options

Limit Articles Displayed by the Following Study Types

What is Cumulative Knowledge?

Cumulative Knowledge is determined by ascribing a numerical value to the various study types weighted in descending order as follows: (1) Meta-Analysis; (2) Human Study; (3) Human: Case Study; (4) Animal: Transgenic; (5) Animal; (6) In Vitro; (7) Review; and (8) Commentary.

Click here for a more thorough explanation.

Quick Summary: 1 associated Problem Substances

Name	Cumulative Knowledge	Article Count	Focus Articles
Proton-Pump Inhibitors	10	1	Log in \| Sign up

Quick Summary: 1 associated Diseases

Name	Cumulative Knowledge	Article Count	Focus Articles
Neuroendocrine Tumors	10	1	Log in \| Sign up

Currently Viewing Free Sample of Member Only Features

Although all 19,000+ articles on GreenMedInfo.com are made entirely free to view as an educational service to the public, we provide a powerful set of enhanced data comprehension and retrieval tools for subscribing members. Above you are viewing a free preview, limited to 2 rows, of the membership feature called "Cumulative Knowledge" (learn more).

The Focus Article Feature is not enabled.

Upgrading to the Member role gives you access to unlimited rows of Cumulative Knowledge data.

To Participate

Click here to login
Click here to create an account

View the Evidence: Adverse Pharmacological Actions

Chronic PPI use resulted in significant increases in CGA (including the tumor marker chromogranin A) and significant increases in gastrin compared to controls.

Click here to read the entire abstract

Pubmed Data : Pancreas. 2012 Mar 28. Epub 2012 Mar 28. PMID: 22460728

Article Published Date : Mar 28, 2012

Study Type : Human Study

Additional Links

Diseases : Neuroendocrine Tumors : CK(10) : AC(1)

Problem Substances : Proton-Pump Inhibitors : CK(218) : AC(27)

Adverse Pharmacological Actions : Circulating Gastrin and Chromogranin A: Elevated : CK(10) : AC(1), Tumor Marker Elevation: Chromogranin : CK(10) : AC(1)

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

Printer-friendly version
Send to friend
PDF version